Clinical Trials Browser

Phase 2 × OTHER_GOV × Fulvestrant × Clear all

NCT05328440 2023-09-25

Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02)

Phase 2 Unknown

Breast Neoplasms

NCT03024580 2019-08-15

MEGA

Phase 2 Unknown

Breast Neoplasms

NCT02530411 2015-08-21

FURVA

Phase 2 Unknown

Neoplasms